Literature DB >> 328206

Disease and acetylation polymorphism.

P K Lunde, K Frislid, V Hansteen.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 328206     DOI： 10.2165/00003088-197702030-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  88 in total

Review 1.  Clinical pharmacokinetics (second of two parts).

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  Pharmaceutical and pharmacokinetic principles in the formulation of a sustained-release procainamide tablet.

Authors:  S G Dahl; D Fremstad; S Jacobsen; I Kvaleid; K H Landmark; P K Lunde; A A Marthinsen; K J Nådland; T Waaler
Journal:  Pharm Acta Helv       Date:  1976

3.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

Review 4.  Metabolic activation: biochemical basis for many drug-induced liver injuries.

Authors:  J R Mitchell; S D Nelson; S S Thorgeirsson; R J McMurtry; E Dybing
Journal:  Prog Liver Dis       Date:  1976

5.  Acetylator status and response to phenelzine in depressed patients.

Authors:  E C Johnstone; W Marsh
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

6.  Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.

Authors:  J H Peters; G R Gordon; L Levy; M A Strokan; R R Jacobson; C D Enna; W F Kirchheimer
Journal:  Am J Trop Med Hyg       Date:  1974-03       Impact factor: 2.345

7.  Determination of isoniazid and metabolites in biological fluids.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharm Sci       Date:  1974-08       Impact factor: 3.534

8.  Comparison of the acetylation of procainamide and sulfadimidine in man.

Authors:  K Frislid; M Berg; V Hansteen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

9.  Antinuclear antibodies during procainamide treatment and drug acetylation.

Authors:  D M Davies; M A Beedie; M D Rawlins
Journal:  Br Med J       Date:  1975-09-20

10.  A CLINICAL STUDY OF ISONIAZID INACTIVATION.

Authors:  A G JESSAMINE; E J HAMILTON; L EIDUS
Journal:  Can Med Assoc J       Date:  1963-12-14       Impact factor: 8.262
View more
  46 in total

1.  Polymorphism of carbon oxidation of drugs and clinical implications.

Authors:  T P Sloan; A Mahgoub; R Lancaster; J R Idle; R L Smith
Journal:  Br Med J       Date:  1978-09-02

Review 2.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 3.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

4.  Acetylator polymorphism in Parkinson's disease.

Authors:  J M Ladero; F J Jimenez; J Benitez; M J Fernandez-Gundin; C Martinez; A Llerena; J Cobaleda; J J Muñoz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  The effect of glucose on acetylation status.

Authors:  D Suhardjono; J Boutagy; G M Shenfield
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

6.  Polymorphic acetylation: lack of influence of rheumatic disease activity and concomitant drug administration.

Authors:  C Astbury; C Beyeler; H A Bird
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

7.  N-acetylation phenotyping with dapsone in a mainland Chinese population.

Authors:  Y Horai; H H Zhou; L M Zhang; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of procainamide.

Authors:  E Karlsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

9.  A rapid method for determination of acetylation phenotype using dapsone.

Authors:  P A Philip; M S Roberts; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

10.  Transient global amnesia: a clinical and EEG study.

Authors:  L C Erli; A Franza; M Viscardi; C A Defanti
Journal:  Ital J Neurol Sci       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.